Quest Diagnostics (NYSE: DGX) is a clinical laboratory services company that processes diagnostic tests ordered by physicians, hospitals, and other healthcare providers. Revenue is transactional, generated each time a specimen is tested and a result is reported, with reimbursement coming from commercial insurers, government payers such as Medicare and Medicaid, and patients paying out of pocket. The filing excerpts provided do not contain sufficient detail to characterize segment revenue splits, test volumes, patient service center counts, or competitive positioning beyond what is stated here. Based solely on the available filing excerpt from the 10-K filed 2026-02-26 (accession 000102207926000015) for the fiscal year ended in that period, further specifics on revenue, geography, leadership, and moat sources cannot be confirmed and are therefore omitted.

Revenue model

Transactional fee-for-service model: revenue is recognized per diagnostic test processed, billed to commercial insurers, Medicare, Medicaid, or patients directly.

Products and services

Clinical laboratory diagnostic testing services.

Customers and end markets

Physicians, hospitals, and other healthcare providers ordering diagnostic tests; payers include commercial health insurers, Medicare, and Medicaid.

Value-chain role

Outsourced clinical laboratory provider sitting between ordering clinicians and payers in the healthcare diagnostics value chain.

Source: SEC 10-K, filed 2026-02-26

Industry: Services-Medical Laboratories Peers: agilon health inc Chemed Corp Cigna Group CVS Health Corp DaVita Inc Labcorp Holdings Inc Oak Street Health, Inc. R1 RCM Inc. /DE Signify Health, Inc.